Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $266000.0.
- Contineum Therapeutics' Other Non-Current Assets rose 876666.67% to $266000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $266000.0, marking a year-over-year increase of 876666.67%. This contributed to the annual value of $3000.0 for FY2024, which is 9976.62% down from last year.
- As of Q3 2025, Contineum Therapeutics' Other Non-Current Assets stood at $266000.0, which was up 876666.67% from $186000.0 recorded in Q2 2025.
- Contineum Therapeutics' 5-year Other Non-Current Assets high stood at $2.6 million for Q1 2024, and its period low was $3000.0 during Q2 2024.
- Moreover, its 3-year median value for Other Non-Current Assets was $95000.0 (2025), whereas its average is $546375.0.
- Within the past 5 years, the most significant YoY rise in Contineum Therapeutics' Other Non-Current Assets was 876666.67% (2025), while the steepest drop was 9984.75% (2025).
- Quarter analysis of 3 years shows Contineum Therapeutics' Other Non-Current Assets stood at $1.3 million in 2023, then crashed by 99.77% to $3000.0 in 2024, then skyrocketed by 8766.67% to $266000.0 in 2025.
- Its Other Non-Current Assets stands at $266000.0 for Q3 2025, versus $186000.0 for Q2 2025 and $4000.0 for Q1 2025.